Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ipratropium bromide
- Therapeutic area
- Respiratory & allergy
- Drug class
- Antimuscarinic bronchodilators
- ATC
- R03
- Strength
- 0.25 mg/mL (0.025%)
- Dosage form
- Nebulizer solution
- Pack
- 5x2mL
- Registration no.
- 033167
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Chiesi Pharmaceuticals (Pvt) Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Atem (Ipratropium bromide) is used for
Ipratropium bromide is a bronchodilator from the anticholinergic group. It relaxes and opens the airways to make breathing easier. It comes as a liquid that is breathed in as a mist through a nebuliser machine, and as an aerosol inhaler. It is a prescription medicine. It controls symptoms but works more slowly than a reliever such as salbutamol, so it is mainly used to keep symptoms under control rather than for sudden attacks.
- Easing and preventing wheezing, breathlessness, coughing and a tight chest in COPD (long-term lung disease, including chronic bronchitis and emphysema)
- Helping with breathing during a COPD flare-up, given through a nebuliser as directed by the care team
- Breathing difficulty in long-term (chronic) asthma, often alongside a reliever medicine such as salbutamol
Get medical help straight away if
- Stop using it and get urgent medical help if wheezing or breathlessness gets worse straight after a dose. Do not use it again unless a doctor tells you to.
- Call an ambulance or go to the emergency department if your breathing is not improving or is getting worse, your chest feels tighter, or the medicine is not working, even if you felt better for a short time.
- Stop using it and get emergency help for signs of a severe allergic reaction: swelling of the eyelids, face, lips, mouth or throat, a tight throat, trouble breathing or swallowing, a rash, hives or itching, or feeling faint (low blood pressure).
- Get urgent help for a fast, pounding or uneven heartbeat (palpitations), or chest pain.
Side effects, warnings and interactions for Ipratropium bromide
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Ipratropium bromide
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Ipratropium bromide is right for you and the dose.
- Asthma: ipratropium is added to the reliever during moderate attacks in hospital or clinic
- Chronic obstructive pulmonary disease (COPD): can be added to a short-acting beta2 agonist during a flare-up, by inhaler or nebuliser
About Atem 0.25 mg/mL (0.025%) nebulizer solution
Atem 0.25 mg/mL (0.025%) nebulizer solution contains Ipratropium bromide 0.25 mg/mL (0.025%). It is registered with DRAP by Chiesi Pharmaceuticals (Pvt) Ltd (registration no. 033167). Its official price is PKR 708.79 for a pack of 5x2mL. This price has applied since 27 July 2026. No other brand of Ipratropium bromide 0.25 mg/mL (0.025%) in this form is listed in Pakistan.
Other brands of Ipratropium bromide 0.25 mg/mL (0.025%) inhalation in Pakistan
No other brand of Ipratropium bromide 0.25 mg/mL (0.025%) inhalation is listed in Pakistan. See all strengths and forms of Ipratropium bromide →
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Atem, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Chiesi Pharmaceuticals (Pvt) Ltd, Lahore
- DRAP registration
- 033167
- Phone
- +92 42 111 244 374
- info.pk@chiesi.com
- Website
- https://www.chiesipakistan.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (5x2mL). Current price PKR 708.79, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Atem 0.25 mg/mL (0.025%), 5x2mL: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/atem-0-25-mg-ml-0-025-033167-5x2ml-chiesi-pharmaceuticals-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 708.79 | 2026-07-27 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 033167Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.